Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Environmental Health Perspectives
|
June 1, 1975
Perspective on chemicals and health
R Eckardt
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 22, 1998
Antitumor activity of docetaxel
J R Eckardt
Clinical Lung Cancer
|
November 20, 2003
Topotecan in relapsed small-cell lung cancer: can good things come in small packages?
John R Eckardt
Oncology
|
October 13, 2001
Feasibility of oral topotecan in previously untreated patients with small-cell lung cancer ineligible for standard therapy
J R Eckardt
The Oncologist
|
December 24, 2004
Emerging role of weekly topotecan in recurrent small cell lung cancer
John R Eckardt
Oncology
|
October 13, 2001
Feasibility of oral topotecan plus intravenous paclitaxel in advanced non-small-cell lung cancer
J R Eckardt
Oncology (Williston Park, N.Y.)
|
March 14, 2003
Second-line treatment of small-cell lung cancer. The case for systemic chemotherapy
John R Eckardt
Anti-Cancer Drugs
|
August 1, 1996
New approaches to the treatment of advanced breast cancer
J R Eckardt
Die Pharmazie
|
January 1, 1970
[Analysis of Kalypnon]
H Usbeck, R Eckardt
Zentralblatt Fur Gynakologie
|
January 1, 1986
[Hysterosalpingography with simultaneous intrauterine pressure measurement. A contribution to invasive sterility diagnosis]
R Eckardt, W Niederlag
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Environmental Health Perspectives
|
June 1, 1975
Perspective on chemicals and health
R Eckardt
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 22, 1998
Antitumor activity of docetaxel
J R Eckardt
Clinical Lung Cancer
|
November 20, 2003
Topotecan in relapsed small-cell lung cancer: can good things come in small packages?
John R Eckardt
Oncology
|
October 13, 2001
Feasibility of oral topotecan in previously untreated patients with small-cell lung cancer ineligible for standard therapy
J R Eckardt
The Oncologist
|
December 24, 2004
Emerging role of weekly topotecan in recurrent small cell lung cancer
John R Eckardt
Oncology
|
October 13, 2001
Feasibility of oral topotecan plus intravenous paclitaxel in advanced non-small-cell lung cancer
J R Eckardt
Oncology (Williston Park, N.Y.)
|
March 14, 2003
Second-line treatment of small-cell lung cancer. The case for systemic chemotherapy
John R Eckardt
Anti-Cancer Drugs
|
August 1, 1996
New approaches to the treatment of advanced breast cancer
J R Eckardt
Die Pharmazie
|
January 1, 1970
[Analysis of Kalypnon]
H Usbeck, R Eckardt
Zentralblatt Fur Gynakologie
|
January 1, 1986
[Hysterosalpingography with simultaneous intrauterine pressure measurement. A contribution to invasive sterility diagnosis]
R Eckardt, W Niederlag
Page
of 8